Accelerated by the COVID-19 pandemic, the healthcare industry is quickly transforming to address the needs of the digital era. Healthcare professionals, drug developers, and patients are all critical adaptors of these new technologies and processes, which means that the pharmaceutical value chain must also prepare to meet this new challenge.